IN2014MN02380A - - Google Patents
Info
- Publication number
- IN2014MN02380A IN2014MN02380A IN2380MUN2014A IN2014MN02380A IN 2014MN02380 A IN2014MN02380 A IN 2014MN02380A IN 2380MUN2014 A IN2380MUN2014 A IN 2380MUN2014A IN 2014MN02380 A IN2014MN02380 A IN 2014MN02380A
- Authority
- IN
- India
- Prior art keywords
- compound
- present
- piperidine derivatives
- novel piperidine
- stereoisomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/452—Piperidinium derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Abstract
The present invention relates to novel piperidine derivatives stereoisomers thereof or pharmaceutically acceptable salts thereof; methods for preparing the compound; and pharmaceutical compositions comprising the compound. The novel piperidine derivatives according to the present invention having an effect as GPR119 agonist can be used for treatment of metabolic disorders including diabetes mellitus (especially type II) and related disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20120062784 | 2012-06-12 | ||
PCT/KR2013/005096 WO2013187646A1 (en) | 2012-06-12 | 2013-06-11 | Piperidine derivatives for gpr119 agonist |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN02380A true IN2014MN02380A (en) | 2015-08-14 |
Family
ID=49758419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2380MUN2014 IN2014MN02380A (en) | 2012-06-12 | 2013-06-11 |
Country Status (18)
Country | Link |
---|---|
US (1) | US9944600B2 (en) |
EP (1) | EP2858986B1 (en) |
JP (3) | JP2015522559A (en) |
KR (1) | KR101535954B1 (en) |
CN (1) | CN104364246B (en) |
BR (1) | BR112014031091A2 (en) |
CA (1) | CA2867114C (en) |
DK (1) | DK2858986T3 (en) |
ES (1) | ES2759010T3 (en) |
HR (1) | HRP20200141T1 (en) |
IN (1) | IN2014MN02380A (en) |
MX (1) | MX365108B (en) |
NZ (1) | NZ630488A (en) |
PH (1) | PH12014502567A1 (en) |
PL (1) | PL2858986T3 (en) |
PT (1) | PT2858986T (en) |
RU (1) | RU2603346C2 (en) |
WO (1) | WO2013187646A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2858986B1 (en) | 2012-06-12 | 2019-10-30 | Chong Kun Dang Pharmaceutical Corp. | Piperidine derivatives as gpr119 agonists |
MX366297B (en) * | 2013-11-26 | 2019-07-04 | Chong Kun Dang Pharmaceutical Corp | Amide derivatives for gpr119 agonist. |
KR101651505B1 (en) * | 2014-05-02 | 2016-08-29 | 현대약품 주식회사 | Novel cyclohexene derivatives, preparation method thereof and pharmaceutical composition for prevention or treatment of the metabolic diseases containing the same as an active ingredient |
WO2015167309A1 (en) * | 2014-05-02 | 2015-11-05 | 현대약품 주식회사 | Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient |
EP3352750A4 (en) * | 2015-11-04 | 2018-08-01 | Hyundai Pharm Co., Ltd. | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient |
US10526345B2 (en) | 2016-04-08 | 2020-01-07 | Mankind Pharma Ltd. | Compounds as GPR119 agonists |
US10954229B2 (en) | 2016-04-08 | 2021-03-23 | Mankind Pharma Ltd. | GPR119 agonist compounds |
US10208030B2 (en) | 2016-04-08 | 2019-02-19 | Mankind Pharma Ltd. | GPR119 agonist compounds |
AU2017276837B2 (en) * | 2016-06-09 | 2021-09-16 | Pramana Pharmaceuticals Inc. | Compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of G protein-coupled receptor 119 |
KR102112173B1 (en) * | 2017-02-28 | 2020-05-19 | 한국화학연구원 | Piperidine-aryl derivatives or pharmaceutically acceptable salt thereof, process for preparation thereof, and pharmaceutical composition containing the same as an active ingredient |
WO2019104418A1 (en) | 2017-11-30 | 2019-06-06 | Pramana Pharmaceuticals Inc. | Compounds containing polysubstituted benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide or benzo[d][1,3]oxathiole 3,3-dioxide and methods/uses thereof as agonists of g protein-coupled receptor 119 |
AR114237A1 (en) * | 2018-02-01 | 2020-08-05 | Japan Tobacco Inc | HETEROCYCLIC AMIDE COMPOUND CONTAINING NITROGEN AND ITS PHARMACEUTICAL USE |
GB201905520D0 (en) | 2019-04-18 | 2019-06-05 | Modern Biosciences Ltd | Compounds and their therapeutic use |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5109002A (en) | 1989-09-08 | 1992-04-28 | Du Pont Merck Pharmaceutical Company | Antipsychotic 1-cycloalkylpiperidines |
ATE247612T1 (en) | 2000-06-26 | 2003-09-15 | Saudi Basic Ind Corp | DIMERIZATION OF OLEFINS |
US7060331B2 (en) | 2000-07-13 | 2006-06-13 | Merck Patent Gmbh | Chiral compounds 1 |
AU2002212282A1 (en) * | 2000-10-20 | 2002-05-06 | Merck Patent G.M.B.H | Chiral binaphthol derivatives |
DE102004037515A1 (en) | 2003-08-22 | 2005-03-17 | Merck Patent Gmbh | New (hetero)cycloalkyl or (hetero)phenyl carboxamide derivatives useful for preparing aldehydes useful as intermediates for liquid crystal compounds |
US20080058339A1 (en) * | 2006-08-30 | 2008-03-06 | Biovitrum | New compounds |
CN101657471B (en) | 2006-12-06 | 2013-07-03 | 史密丝克莱恩比彻姆公司 | Bicyclic compounds and use as antidiabetics |
PL2114933T3 (en) | 2007-01-04 | 2012-02-29 | Prosidion Ltd | Piperidine gpcr agonists |
JP5489997B2 (en) | 2007-07-19 | 2014-05-14 | シマベイ セラピューティクス, インコーポレーテッド | N-aza cyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of RUP3 or GPRl 19 receptors for the treatment of diabetes and metabolic diseases |
JP5465177B2 (en) | 2007-09-20 | 2014-04-09 | アイアールエム・リミテッド・ライアビリティ・カンパニー | Compounds and compositions as modulators of GPR119 activity |
WO2009106561A1 (en) | 2008-02-27 | 2009-09-03 | Biovitrum Ab (Publ) | Pyrazine compounds for treating gpr119 related disorders |
WO2009106565A1 (en) | 2008-02-27 | 2009-09-03 | Biovitrum Ab (Publ) | Agonists of gpr119 |
JP5309216B2 (en) | 2008-07-11 | 2013-10-09 | アイアールエム・リミテッド・ライアビリティ・カンパニー | 4-phenoxymethylpiperidines as modulators of GPR119 activity |
WO2010048149A2 (en) | 2008-10-20 | 2010-04-29 | Kalypsys, Inc. | Heterocyclic modulators of gpr119 for treatment of disease |
AR077642A1 (en) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME |
AR077638A1 (en) * | 2009-07-15 | 2011-09-14 | Lilly Co Eli | COMPOSITE OF (METHANOSULPHONYL -PIPERIDIN) - (ALCOXI-ARIL) -TETRAHIDRO- PYRIDINE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE TO PREPARE A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF DIABETES OR OBESITY |
CA2795513A1 (en) * | 2010-04-06 | 2011-10-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2011145718A1 (en) | 2010-05-21 | 2011-11-24 | 田辺三菱製薬株式会社 | Novel pyrrolo[2,3-d]pyrimidine compound |
TW201202230A (en) | 2010-05-24 | 2012-01-16 | Mitsubishi Tanabe Pharma Corp | Novel quinazoline compound |
CN102432598A (en) * | 2010-09-29 | 2012-05-02 | 江苏恒瑞医药股份有限公司 | Tricyclic compound, preparation method thereof and pharmaceutical application thereof |
WO2012069917A1 (en) * | 2010-11-26 | 2012-05-31 | Lupin Limited | Bicyclic gpr119 modulators |
WO2012077655A1 (en) | 2010-12-07 | 2012-06-14 | 塩野義製薬株式会社 | Spiro derivative having gpr119 agonist activity |
JP2014159376A (en) | 2011-06-17 | 2014-09-04 | Taisho Pharmaceutical Co Ltd | Azaspiroalkane compound |
EP2858986B1 (en) | 2012-06-12 | 2019-10-30 | Chong Kun Dang Pharmaceutical Corp. | Piperidine derivatives as gpr119 agonists |
-
2013
- 2013-06-11 EP EP13804551.3A patent/EP2858986B1/en active Active
- 2013-06-11 CN CN201380030772.3A patent/CN104364246B/en not_active Expired - Fee Related
- 2013-06-11 PT PT138045513T patent/PT2858986T/en unknown
- 2013-06-11 PL PL13804551T patent/PL2858986T3/en unknown
- 2013-06-11 KR KR1020130066224A patent/KR101535954B1/en active IP Right Grant
- 2013-06-11 IN IN2380MUN2014 patent/IN2014MN02380A/en unknown
- 2013-06-11 WO PCT/KR2013/005096 patent/WO2013187646A1/en active Application Filing
- 2013-06-11 ES ES13804551T patent/ES2759010T3/en active Active
- 2013-06-11 NZ NZ630488A patent/NZ630488A/en not_active IP Right Cessation
- 2013-06-11 MX MX2014015057A patent/MX365108B/en active IP Right Grant
- 2013-06-11 RU RU2014142328/04A patent/RU2603346C2/en active
- 2013-06-11 JP JP2015515954A patent/JP2015522559A/en active Pending
- 2013-06-11 US US14/407,214 patent/US9944600B2/en not_active Expired - Fee Related
- 2013-06-11 CA CA2867114A patent/CA2867114C/en not_active Expired - Fee Related
- 2013-06-11 BR BR112014031091A patent/BR112014031091A2/en not_active Application Discontinuation
- 2013-06-11 DK DK13804551T patent/DK2858986T3/en active
-
2014
- 2014-11-18 PH PH12014502567A patent/PH12014502567A1/en unknown
-
2017
- 2017-01-06 JP JP2017000926A patent/JP2017105785A/en active Pending
-
2019
- 2019-02-01 JP JP2019017078A patent/JP2019104741A/en not_active Ceased
-
2020
- 2020-01-29 HR HRP20200141TT patent/HRP20200141T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN104364246B (en) | 2018-05-22 |
EP2858986B1 (en) | 2019-10-30 |
PH12014502567B1 (en) | 2015-01-21 |
PL2858986T3 (en) | 2020-03-31 |
PH12014502567A1 (en) | 2015-01-21 |
AU2013275090A1 (en) | 2014-09-25 |
US20150166480A1 (en) | 2015-06-18 |
US9944600B2 (en) | 2018-04-17 |
CA2867114A1 (en) | 2013-12-19 |
DK2858986T3 (en) | 2019-11-25 |
BR112014031091A2 (en) | 2017-08-22 |
HRP20200141T1 (en) | 2020-04-03 |
RU2014142328A (en) | 2016-07-27 |
RU2603346C2 (en) | 2016-11-27 |
KR101535954B1 (en) | 2015-07-10 |
KR20130139176A (en) | 2013-12-20 |
CN104364246A (en) | 2015-02-18 |
EP2858986A1 (en) | 2015-04-15 |
NZ630488A (en) | 2016-07-29 |
CA2867114C (en) | 2016-02-23 |
PT2858986T (en) | 2019-11-29 |
EP2858986A4 (en) | 2015-11-11 |
JP2015522559A (en) | 2015-08-06 |
ES2759010T3 (en) | 2020-05-07 |
JP2017105785A (en) | 2017-06-15 |
MX2014015057A (en) | 2015-06-05 |
JP2019104741A (en) | 2019-06-27 |
MX365108B (en) | 2019-05-23 |
WO2013187646A1 (en) | 2013-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014502567A1 (en) | Piperidine derivatives for gpr119 agonist | |
EA201491060A1 (en) | NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
IN2014MN02598A (en) | ||
IN2014MN02106A (en) | ||
PH12015501452A1 (en) | Novel quinolone derivatives | |
PH12014502363A1 (en) | N-aryltriazole compounds as lpar antagonists | |
MX2014000341A (en) | Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease. | |
PH12014502789A1 (en) | N-alkyltriazole compounds as lpar antagonists | |
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
TN2013000309A1 (en) | Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents | |
GEP20146146B (en) | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 | |
NZ746950A (en) | Heterocyclic gpr119 agonist compounds | |
PH12016500394A1 (en) | Polymorphic form of pyrrole derivative and intermediate thereof | |
NZ720328A (en) | Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease | |
MX355072B (en) | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists. | |
EA201400064A1 (en) | OPHTHALMIC PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION THAT CONTAINS REGORAPHENIB | |
EA201890684A1 (en) | FLUORINDOL DERIVATIVES AS A POSITIVE ALLOSTERIC MODULATORS OF MUSCARINE M1 RECEPTOR | |
PH12016500980A1 (en) | Amide derivatives for gpr119 agonist | |
IN2015DN02109A (en) | ||
MX2012006287A (en) | Azaindole glucokinase activators. | |
MX338438B (en) | Isoindolinone derivatives. | |
MX2013014950A (en) | Compounds for the treatment of cancers associated with human papillomavirus. | |
TN2013000441A1 (en) | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists | |
AU2012296262A8 (en) | Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (CETP) inhibitors |